Lever 3 — remove the sensitising drive

Lever 3 — remove the sensitising drive. Lever 3 removes the upstream sensitising drive — nerve-growth-factor (NGF→TrkA) and CGRP signalling that turn up the gain of the pain pathway. For every L3 target, γ only places the gene in the map; the ligand→receptor→sensitisation mechanism is cited biology, never derived by the read, and is enforced as [O] by

This lever groups the targets whose promoter reads place them in the lever 3 — remove the sensitising drive. Each target keeps its own page with its read, grades, citation, and firewall; the lever direction is cited Layer-2 biology, the reads are [V], and all clinical magnitudes are [O].

What this lever does

Lever 3 removes the upstream sensitising drive — nerve-growth-factor (NGF→TrkA) and CGRP signalling that turn up the gain of the pain pathway. For every L3 target, γ only places the gene in the map; the ligand→receptor→sensitisation mechanism is cited biology, never derived by the read, and is enforced as [O] by a fail-closed L3-honesty gate.

Targets in this lever

Each row links to that target's own self-contained page (its read, grades, citation, and firewall).

genechannel / proteinγ|hsp|selectivity (cited)
CALCBbeta-CGRP (ligand)γ 1.5169|hsp| 0.71909CGRP isoform (trigeminal/enteric)
NTRK1TrkA (NGF receptor)γ 1.5036|hsp| 0.709654nociceptor + some CNS (CIPA on LOF)
CALCAalpha-CGRP (ligand)γ 1.4876|hsp| 0.698357trigeminovascular; de-risked axis (gepants + anti-CGRP mAbs approved)
NGFNGF (nerve growth factor, ligand)γ 1.4688|hsp| 0.68516peripheral sensitiser; anti-NGF efficacy in OA/LBP (rapidly-progressive-OA caveat)
RAMP1RAMP1 (receptor-activity-modifying protein 1)γ 1.4249|hsp| 0.654673confers CGRP specificity on CLR
CALCRLCALCRL (calcitonin-receptor-like receptor)γ 1.2122|hsp| 0.5137with RAMP1 forms the CGRP receptor; erenumab/gepant target